Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meredian was an industrial biotechnology company focused on biodegradable bioplastics rather than therapeutics, diagnostics, or healthcare services. The company developed and manufactured polyhydroxyalkanoate (PHA)-based and related biopolymer materials for packaging and consumer applications, emphasizing sustainable alternatives to petroleum-based plastics. Meredian was associated with Meredian Holdings Group and later became part of Danimer Scientific through a corporate rebranding and consolidation path. Its business centered on polymer production, formulation, and scale-up rather than a drug pipeline. As a result, it is not a life science, biotech drug-development, pharma, or healthcare company in the sense implied by the requested schema.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meredian.